Neuren Pharmaceuticals Ltd (NEU) - Total Liabilities

Latest as of June 2025: AU$7.98 Million AUD ≈ $5.64 Million USD

Based on the latest financial reports, Neuren Pharmaceuticals Ltd (NEU) has total liabilities worth AU$7.98 Million AUD (≈ $5.64 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Neuren Pharmaceuticals Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Neuren Pharmaceuticals Ltd - Total Liabilities Trend (2000–2024)

This chart illustrates how Neuren Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Neuren Pharmaceuticals Ltd's balance sheet.

Neuren Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuren Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Monarch Casino & Resort Inc NASDAQ:MCRI	USA	$175.18 Million
Kelington Group Bhd KLSE:0151	Malaysia	RM645.95 Million
China Publishing & Media Hldg SHG:601949	China	CN¥5.27 Billion
Sixth Street Specialty Lending Inc NYSE:TSLX	USA	$1.99 Billion
Zhengzhou GL Tech Co Ltd SHE:300480	China	CN¥641.74 Million
Solvac S.A. BR:SOLV	Belgium	€215.41 Million
GCS Holdings TWO:4991	Taiwan	NT$521.28 Million
Bank of Chongqing Co Ltd F:CQN	Germany	€967.73 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down Neuren Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NEU net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	40.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.75	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuren Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuren Pharmaceuticals Ltd (2000–2024)

The table below shows the annual total liabilities of Neuren Pharmaceuticals Ltd from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$45.80 Million ≈ $32.41 Million	+7.11%
2023-12-31	AU$42.76 Million ≈ $30.26 Million	+2448.45%
2022-12-31	AU$1.68 Million ≈ $1.19 Million	+108.97%
2021-12-31	AU$803.00K ≈ $568.17K	+6.64%
2020-12-31	AU$753.00K ≈ $532.80K	+34.70%
2019-12-31	AU$559.00K ≈ $395.53K	-71.67%
2018-12-31	AU$1.97 Million ≈ $1.40 Million	+24.87%
2017-12-31	AU$1.58 Million ≈ $1.12 Million	-22.05%
2016-12-31	AU$2.03 Million ≈ $1.43 Million	-18.98%
2015-12-31	AU$2.50 Million ≈ $1.77 Million	-17.37%
2014-12-31	AU$3.03 Million ≈ $2.14 Million	+47.13%
2013-12-31	AU$2.06 Million ≈ $1.46 Million	-3.89%
2012-12-31	AU$2.14 Million ≈ $1.52 Million	+27.20%
2011-12-31	AU$1.68 Million ≈ $1.19 Million	-22.90%
2010-12-31	AU$2.18 Million ≈ $1.55 Million	-25.64%
2009-12-31	AU$2.94 Million ≈ $2.08 Million	-1.19%
2008-12-31	AU$2.97 Million ≈ $2.10 Million	-57.76%
2007-12-31	AU$7.04 Million ≈ $4.98 Million	+108.31%
2006-12-31	AU$3.38 Million ≈ $2.39 Million	+10.88%
2005-12-31	AU$3.05 Million ≈ $2.16 Million	-27.41%
2004-12-31	AU$4.20 Million ≈ $2.97 Million	-72.78%
2003-12-31	AU$15.41 Million ≈ $10.91 Million	+921.40%
2002-12-31	AU$1.51 Million ≈ $1.07 Million	-91.01%
2001-12-31	AU$16.78 Million ≈ $11.87 Million	+120.34%
2000-12-31	AU$7.62 Million ≈ $5.39 Million	--

About Neuren Pharmaceuticals Ltd

AU:NEU Australia Biotechnology

Market Cap

$1.85 Billion

AU$2.62 Billion AUD

Market Cap Rank

#6811 Global

#161 in Australia

Share Price

AU$20.68

Change (1 day)

+0.68%

52-Week Range

AU$11.28 - AU$23.64

All Time High

AU$25.11